Share this Article
Hui CK
Correspondence: Dr Chee-Kin Hui, bckhui@gmail.com
ABSTRACT
The use of intrauterine devices (IUDs) have been widespread since the 1960s. In 2002, the World Health Organization estimated that approximately 160 million women worldwide use IUDs. However, IUDs are associated with short-term complications such as vaginal bleeding, pelvic discomfort, dyspareunia and pelvic infection. Herein, we report the case of a woman who had recurrent urinary tract infection (UTI) due to the use of an IUD, even after treatment. The patient developed four episodes of UTI within a seven-month period after IUD insertion. During each episode of UTI, extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli(E. coli) was cultured from the patient’s midstream urine. The IUD was finally removed, and culture of the removed IUD was positive for ESBL-producing E. coli. An infected IUD as a source of recurrent UTI should be considered in women with IUD in situ who develop recurrent UTI even after treatment.
Keywords: extended-spectrum beta-lactamase-producing Escherichia coli, intrauterine device, urinary tract infection
Singapore Med J 2014; 55(2): e28-e30; http://dx.doi.org/10.11622/smedj.2013213
REFERENCES
| 1. UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. A plethora of IUDs: but how safe, how effective? Prog Reprod Health Res 2002; 60:3. | ||||
| 2. Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine devise insertion: is the incidence higher than previously reported? Contraception 2003; 67:53-6. http://dx.doi.org/10.1016/S0010-7824(02)00417-1 | ||||
| 3. Grimes DA. Intrauterine device and upper genital tract infection. Lancet 2000; 356:1013-9. http://dx.doi.org/10.1016/S0140-6736(00)02699-4 | ||||
| 4. Bonnez W, Lattimer G, Mohanraj NA, Johnson TH. Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device. J Clin Microbiol 1985; 21:273-5. | ||||
| 5. Burkman R, Schlesselman S, McCaffrey L, Gupta PK, Spence M. The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease. Am J Obstet Gynaecol 1982; 143:585-9. | ||||
| 6. Elhag KM, Bahar AM, Mubarak AA. The effect of copper intra-uterine contraceptive device on the microbial ecology of the female genital tract. J Med Microbiol 1988; 25:245-51. http://dx.doi.org/10.1099/00222615-25-4-245 | ||||
| 7. Keebler C, Chatwani A, Schwartz R. Actinomycosis infection associated with intrauterine contraceptive devices. Am J Obstet Gynaecol 1983; 145:596-9. | ||||
| 8. Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systemic review. Contraception 2006; 73:145-53. http://dx.doi.org/10.1016/j.contraception.2005.08.007 | ||||
| 9. Charonis G, Larsson PG. Prolonged use of intrauterine contraceptive device as a risk factor for tubo-ovarian abscess. Acta Obstet Gynecol Scand 2009; 88:680-4. http://dx.doi.org/10.1080/00016340902893678 | ||||
| 10. Meirik O. Intrauterine devices- upper and lower genital tract infections. Contraception 2007; 75(6 Suppl):S41-7. http://dx.doi.org/10.1016/j.contraception.2006.12.017 | ||||
| 11. Zahran MM, Osman MI, Kamel M, Fayad M, Mooro H, Youssef AF. Effects of contraceptive pills and intrauterine devices on urinary bladder. Urology 1976; 8:567-74. http://dx.doi.org/10.1016/0090-4295(76)90519-7 | ||||
| 12. Fallahian M, Mashhady E, Amiri Z. Asymptomatic bacteriuria in users of intrauterine devices. Urol J 2005; 2:157-9. | ||||